Taken collectively, our findings suggest that RdB/IL23/p35 may create a tumor microenvironment more favorable to activate tumor-specific immune cells via simultaneous high expression of IL-12, IL-23, IFN-γ, and TNF-αin the immunosuppressive microenvironment of tumor. This evidence concerns the gene IFNG and neoplasm.